AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
202.08
+1.20 (0.60%)
At close: Feb 21, 2025, 4:00 PM
201.50
-0.58 (-0.29%)
After-hours: Feb 21, 2025, 7:19 PM EST
AbbVie Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
Revenue | 56,334 | 54,318 | 58,054 | 56,197 | 45,804 | Upgrade
|
Revenue Growth (YoY) | 3.71% | -6.44% | 3.30% | 22.69% | 37.69% | Upgrade
|
Cost of Revenue | 16,725 | 16,726 | 16,527 | 17,314 | 15,257 | Upgrade
|
Gross Profit | 39,609 | 37,592 | 41,527 | 38,883 | 30,547 | Upgrade
|
Selling, General & Admin | 13,479 | 12,904 | 14,584 | 11,872 | 9,867 | Upgrade
|
Research & Development | 8,315 | 7,038 | 6,487 | 6,820 | 6,003 | Upgrade
|
Other Operating Expenses | -7 | -10 | 228 | 432 | - | Upgrade
|
Operating Expenses | 21,787 | 19,932 | 21,299 | 19,124 | 15,870 | Upgrade
|
Operating Income | 17,822 | 17,660 | 20,228 | 19,759 | 14,677 | Upgrade
|
Interest Expense | -2,808 | -2,224 | -2,230 | -2,423 | -2,454 | Upgrade
|
Interest & Investment Income | 648 | 540 | 186 | 39 | 174 | Upgrade
|
Currency Exchange Gain (Loss) | -21 | -146 | -148 | -51 | -71 | Upgrade
|
Other Non Operating Income (Expenses) | 271 | 190 | 142 | 55 | 113 | Upgrade
|
EBT Excluding Unusual Items | 15,912 | 16,020 | 18,178 | 17,379 | 12,439 | Upgrade
|
Merger & Restructuring Charges | -282 | -119 | -539 | -587 | -1,912 | Upgrade
|
Gain (Loss) on Sale of Assets | - | - | 172 | - | - | Upgrade
|
Asset Writedown | -4,476 | -4,230 | -876 | - | - | Upgrade
|
Legal Settlements | -910 | 485 | - | - | - | Upgrade
|
Other Unusual Items | -3,771 | -5,128 | -2,761 | -2,679 | -5,753 | Upgrade
|
Pretax Income | 3,716 | 6,250 | 13,477 | 12,989 | 3,398 | Upgrade
|
Income Tax Expense | -570 | 1,377 | 1,632 | 1,440 | -1,224 | Upgrade
|
Earnings From Continuing Operations | 4,286 | 4,873 | 11,845 | 11,549 | 4,622 | Upgrade
|
Minority Interest in Earnings | -8 | -10 | -9 | -7 | -6 | Upgrade
|
Net Income | 4,278 | 4,863 | 11,836 | 11,542 | 4,616 | Upgrade
|
Preferred Dividends & Other Adjustments | 40 | 43 | 54 | 74 | 60 | Upgrade
|
Net Income to Common | 4,238 | 4,820 | 11,782 | 11,468 | 4,556 | Upgrade
|
Net Income Growth | -12.03% | -58.91% | 2.55% | 150.04% | -41.44% | Upgrade
|
Shares Outstanding (Basic) | 1,769 | 1,768 | 1,771 | 1,770 | 1,667 | Upgrade
|
Shares Outstanding (Diluted) | 1,773 | 1,773 | 1,778 | 1,777 | 1,673 | Upgrade
|
Shares Change (YoY) | - | -0.28% | 0.06% | 6.22% | 12.74% | Upgrade
|
EPS (Basic) | 2.40 | 2.73 | 6.65 | 6.48 | 2.73 | Upgrade
|
EPS (Diluted) | 2.39 | 2.72 | 6.63 | 6.45 | 2.72 | Upgrade
|
EPS Growth | -12.13% | -58.97% | 2.79% | 137.13% | -48.48% | Upgrade
|
Free Cash Flow | 17,832 | 22,062 | 24,248 | 21,990 | 16,790 | Upgrade
|
Free Cash Flow Per Share | 10.06 | 12.44 | 13.64 | 12.37 | 10.04 | Upgrade
|
Dividend Per Share | 6.290 | 5.990 | 5.710 | 5.310 | 4.840 | Upgrade
|
Dividend Growth | 5.01% | 4.90% | 7.53% | 9.71% | 10.25% | Upgrade
|
Gross Margin | 70.31% | 69.21% | 71.53% | 69.19% | 66.69% | Upgrade
|
Operating Margin | 31.64% | 32.51% | 34.84% | 35.16% | 32.04% | Upgrade
|
Profit Margin | 7.52% | 8.87% | 20.29% | 20.41% | 9.95% | Upgrade
|
Free Cash Flow Margin | 31.65% | 40.62% | 41.77% | 39.13% | 36.66% | Upgrade
|
EBITDA | 26,208 | 26,358 | 28,695 | 28,280 | 21,148 | Upgrade
|
EBITDA Margin | 46.52% | 48.53% | 49.43% | 50.32% | 46.17% | Upgrade
|
D&A For EBITDA | 8,386 | 8,698 | 8,467 | 8,521 | 6,471 | Upgrade
|
EBIT | 17,822 | 17,660 | 20,228 | 19,759 | 14,677 | Upgrade
|
EBIT Margin | 31.64% | 32.51% | 34.84% | 35.16% | 32.04% | Upgrade
|
Effective Tax Rate | - | 22.03% | 12.11% | 11.09% | - | Upgrade
|
Advertising Expenses | 2,100 | 2,200 | 2,000 | 2,100 | 1,800 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.